Physician profile
Christopher J Smith
NPI 1841214624
$2,785.04
in general payments reported to CMS, 2019-2025
17 companies · $948 in 2025
The $948 reported for 2025 was more than what 81% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $149 · 2021: $455 · 2022: $247 · 2023: $624 · 2024: $196 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Consulting Fee: $631 · Travel and Lodging: $52.92 · Education: $17.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.85 |
| Consulting Fee | $631.25 |
| Travel and Lodging | $52.92 |
| Education | $17.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chugai Pharmaceutical Co., LTD. | $684.17 | 2025 | |
| Abbvie INC. | $504.23 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $440.31 | 2022-2025 | Dupixent |
| Qol Medical, LLC | $358.77 | 2019-2024 | Sucraid, Sucraid |
| Mirum Pharmaceuticals, INC. | $218.92 | 2022-2023 | Livmarli |
| Takeda Pharmaceuticals U.S.A., INC. | $106.95 | 2020-2025 | Eohilia, Adcetris |
| Amgen INC. | $87.39 | 2023-2024 | Amjevita, Actimmune |
| Horizon Therapeutics Plc | $85.75 | 2019-2022 | |
| Genzyme Corporation | $74.27 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $72.99 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $36.87 | 2024-2025 | Bylvay |
| Biocon Biologics INC | $33.58 | 2025 | Yesintek |
| Redhill Biopharma INC. | $20.53 | 2020 | |
| Fresenius Kabi USA, LLC | $16.24 | 2023 | |
| Sandoz INC. | $15.74 | 2024 | Hyrimoz |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $14.69 | 2023 | |
| Alfasigma USA, INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.